227 related articles for article (PubMed ID: 30342782)
1. Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital.
Béjar-Serrano S; Del Pozo P; Fernández-de la Varga M; Benlloch S
Gastroenterol Hepatol; 2019 Apr; 42(4):228-238. PubMed ID: 30342782
[TBL] [Abstract][Full Text] [Related]
2. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of bacterial infections in patients with liver cirrhosis. Experience in a Spanish tertiary health center.
Klímová K; Padilla C; Ávila JC; Clemente G; Ochoa A
Biomedica; 2016 Mar; 36(1):121-32. PubMed ID: 27622445
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
7. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission.
Gupta T; Lochan D; Verma N; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla YK; Dhiman RK
J Gastroenterol Hepatol; 2020 Mar; 35(3):461-466. PubMed ID: 31334860
[TBL] [Abstract][Full Text] [Related]
8. New antibiotic strategies in patients with cirrhosis and bacterial infection.
Fernández J; Acevedo J
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
[TBL] [Abstract][Full Text] [Related]
9. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
[TBL] [Abstract][Full Text] [Related]
10. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
[TBL] [Abstract][Full Text] [Related]
12. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.
Zhao R; Ma J; Li P; Fang H; Sun S; Wu W; Chen J; Zhao H; Jin L; Shi Y; Sheng J
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1167-1174. PubMed ID: 30152255
[TBL] [Abstract][Full Text] [Related]
14. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome.
Sargenti K; Prytz H; Strand A; Nilsson E; Kalaitzakis E
Liver Int; 2015 Feb; 35(2):391-400. PubMed ID: 25039438
[TBL] [Abstract][Full Text] [Related]
15. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
Marciano S; Gutierrez-Acevedo MN; Barbero S; Del C Notari L; Agozino M; Fernandez JL; Anders MM; Grigera N; Antinucci F; Orozco Ganem OF; Murga MD; Perez D; Palazzo A; Martinez Rejtman L; Duarte IG; Vorobioff J; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Bosia JD; Borzi SM; Stieben TE; Masola A; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz P; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Bellizzi C; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):481-491. PubMed ID: 36820931
[TBL] [Abstract][Full Text] [Related]
16. Impact of Prophylactic Norfloxacin in Multidrug Resistant Bacterial Infections in the Early Liver Posttransplant Period.
Pérez-Cameo C; Oriol I; Lung M; Lladó L; Dopazo C; Nuvials X; Los-Arcos I; Sabé N; Castells L; Len O
Exp Clin Transplant; 2023 Mar; 21(3):236-244. PubMed ID: 36987799
[TBL] [Abstract][Full Text] [Related]
17. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
[TBL] [Abstract][Full Text] [Related]
18. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
[TBL] [Abstract][Full Text] [Related]
19. Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis.
Di Cola S; Gazda J; Lapenna L; Ceccarelli G; Merli M
JHEP Rep; 2023 May; 5(5):100703. PubMed ID: 36844944
[TBL] [Abstract][Full Text] [Related]
20. Infections complicating cirrhosis.
Piano S; Brocca A; Mareso S; Angeli P
Liver Int; 2018 Feb; 38 Suppl 1():126-133. PubMed ID: 29427501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
